Megadose Methylprednisolone (MDMP) for Hemangiomatosis
Journal Title: Turkish Journal of Hematology - Year 2012, Vol 29, Issue 4
Abstract
To the Editor, Dr. Küpeli and his colleagues[1] should be congratulated for their success in treating hemangiomatosis, which could be life threatining depending on the localization of hemangiomas, with propranolol. I prefer the term infantile hemangiomatosis instead of segmental hemangiomatosis[2] for the authors’ patient. My primary reason in writing this letter is to clarify MDMP treatment, which caused severe cushingoid appearance in the patient prior to propranolol treatment.
Authors and Affiliations
Şinasi Özsoylu
Keywords
Related Articles
- EP ID EP137497
- DOI 10.5505/tjh.2012.55706
- Views 71
- Downloads 0
Erythema Annulare Centrifugum ve Tekrarlayan Polikondritle Birliktelik Gösteren Akut Miyeloid Lösemi: Bir Olgu Sunumu
Kasabach-Merritt Sendromu Tedavisi Hakkında
A Novel Homozygous Nucleotide Deletion in the JAK2 Gene in a Pediatric Patient with B-cell Precursor Acute Lymphoblastic Leukemia
To the Editor, Janus kinase 2 (JAK2) is a protein tyrosine kinase that transduces cellular signals through the Janus kinase signal transducer and an activator of transcription pathways (JAK-STAT), which mediates c...
Reply: “Auer Rod-Like Inclusions in Reactive Plasma Cells in a Case of Acute Myeloid Leukemia”
.
Kan Bağışı: Anket Sonuçları